ARCHIVES

Investigators Unlocking Drug Resistance Secrets, NCI Study, Bristol-Myers Meeting Reports Show

This article is from The Cancer Letter archive.

Vol. 12 No. 46 | November 28, 1986

Download PDF Visit The Full Archive

Related Articles

FDA Updates Safety Labeling Of 5-Alpha Reductase Inhibitors

June 24, 2011

Fallout Over PSA Guidance Continues—Specialty Groups Dissent, Congress Attacks

July 20, 2012

After A One-Month Retirement, Becker Returns To M.D. Anderson As Research Prof.

November 30, 2001

NCI Audit Finds “Low Quality” Research At Calif. Foundation

June 17, 1994

Drug Slows Tumor Growth In Metastatic Kidney Cancer

July 26, 2002

Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI

March 22, 2013